Please Wait
Applying Filters...
menu
    • menu
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Lacutamab

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Innate Pharma Unveils 2025 Financials And Business Update
    Innate Pharma Unveils 2025 Financials And Business Update

    26 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-26/innate-pharma-reports-full-year-2025-financial-results-and-business-update

    PHARMIWEB
    26 Mar 2026
    Share Share
    Innate Pharma Announces FDA Clearance to Proceed With TELLOMAK 3
    Innate Pharma Announces FDA Clearance to Proceed With TELLOMAK 3

    10 Nov 2025

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20251109757297/en/Innate-Pharma-Announces-FDA-Clearance-to-Proceed-With-TELLOMAK-3-a-Confirmatory-Phase-3-Trial-of-Lacutamab-in-CTCL

    BUSINESS WIRE
    10 Nov 2025
    Share Share
    Innate Pharma Hosts Lacutamab Event On October 28, 2025
    Innate Pharma Hosts Lacutamab Event On October 28, 2025

    14 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-14/innate-pharma-to-host-analyst-and-investor-event-on-lacutamab-on-october-28-2025

    PHARMIWEB
    14 Oct 2025
    Share Share
    Innate Pharma Reports Durable Lacutamab Results
    Innate Pharma Reports Durable Lacutamab Results

    23 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250522071107/en/Innate-Pharma-Highlights-Durable-Responses-to-Lacutamab-in-Sezary-Syndrome-and-Mycosis-Fungoides

    BUSINESSWIRE
    23 May 2025
    Share Share
    Innate Pharma’s Lacutamab Gets FDA Breakthrough Therapy For SS
    Innate Pharma’s Lacutamab Gets FDA Breakthrough Therapy For SS

    17 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250216384344/en

    BUSINESSWIRE
    17 Feb 2025
    Share Share
    Innate Pharma: Positive Phase 2 Lacutamab Data In Mycosis Fungoides
    Innate Pharma: Positive Phase 2 Lacutamab Data In Mycosis Fungoides

    04 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240603023665/en

    BUSINESSWIRE
    04 Jun 2024
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.